Company news
Eyebright Medical Technology (Beijing) Co., Ltd. news in 2025
Eyebright Medical Technology (Beijing) Co., Ltd.'s news releases, calls and decks from 2025, newest first.
Announcement on Convening the Q3 2025 Performance Briefing
November 20, 2025
Announcement on Circulation of Restricted Shares Issued to Specific Objects by Simplified Procedure
November 4, 2025
Report for Q3 2025
October 29, 2025
Announcement on Voluntary Disclosure of Approval for Market Launch of the Extended Depth-of-Focus Intraocular Lens (EDOF IOL) Through the Special Review Process for Innovative Medical Devices
September 26, 2025
Announcement on the Result of Shareholding Reduction by Shareholder and Equity Change Reaching the 1% Scale
September 4, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
August 27, 2025
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1%
August 7, 2025
Announcement on Implementation of Dividend Distribution for 2024
July 11, 2025
Announcement on Adjusting Total Cash Dividends for 2024 Annual Profit Distribution
June 27, 2025
Announcement on Changing Registered Capital, Amending the Articles of Association, and Handling Industrial and Commercial Change Registration
June 19, 2025
Announcement on Share Reduction Plan for Shareholders
June 3, 2025
Announcement on Cancellation of Some Restricted Stocks Granted yet Unvested in 2021 Restricted Stock Incentive Plan
May 29, 2025
Announcement on Results of Issuing Shares to Specific Objects by Summary Procedure and Changes in Capital Stock in 2024
May 13, 2025
Announcement on Signing Three-party and Four-party Supervision Agreements for Deposit of Raised Fund in Special Account
May 6, 2025
Eyebright Medical Published its 2024 Environmental, Social and Governance Report
April 22, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
April 16, 2025
Announcement on Approval of Application for Issuance of Shares to Specific Objects via Summary Procedure by the Shanghai Stock Exchange in 2024
March 12, 2025
Announcement on the Expiry of Planned Time for Shareholders with Over 5% Shares to Reduce Shares and Results of Share Reduction
March 10, 2025
Announcement on the Acceptance of Application for Issuance of Shares to Specific Objects via Summary Procedure by the Shanghai Stock Exchange
February 28, 2025
Announcement on Diluted Immediate Return, Remedial Measures, and Related Entity Commitments for Issuance of Shares to Specific Objects by Summary Procedure (Second Revised)
February 25, 2025
Announcement on the Release of Pledge of Shares by Shareholders
February 12, 2025
Announcement on Implementation Results of Share Repurchase
February 6, 2025
Announcement on the Voluntary Disclosure of the Phakic Intraocular Lens Being Approved for Marketing through the Special Review Procedure for Innovative Medical Devices
January 7, 2025
Announcement on Progress in Repurchasing Shares through Call Auction
January 3, 2025